TY  - BOOK
ED  - United States.
TI  - Examining the impact of voluntary restricted distribution systems in the pharmaceutical supply chain: hearing before the Subcommittee on Healthcare, Benefits, and Administrative Rules of the Committee on Oversight and Government Reform, House of Representatives, One Hundred Fifteenth Congress, first session, March 22, 2017
AV  - KF27 .O9435 2017c
PY  - 2017///
CY  - Washington
PB  - U.S. Government Publishing Office
KW  - Pharmaceutical industry
KW  - Corrupt practices
KW  - United States
KW  - Pharmaceutical policy
KW  - Generic drugs
KW  - Development
KW  - Prescription pricing
KW  - Competition
KW  - Consumer protection
KW  - Legislative hearings
KW  - lcgft
N1  - "Serial no. 115-33."; Shipping list no.: 2018-0099-M; CRDP Program record; Includes bibliographical references; Microfiche; [Washington, D.C.]; U.S. Government Printing Office; [2018]; 1 microfiche : negative
ER  -